Checkpoint Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning. I'm James Oliviero, Chief Executive Officer, President, and Director of Checkpoint Therapeutics, and I'll be presiding over today's virtual meeting of stockholders. On behalf of our company, I want to welcome you to our 2022 annual meeting of stockholders, which is now called to order. We are very pleased to have each of you in attendance at today's virtual meeting.
Let me begin by introducing the other directors of the company in attendance by means of remote communication. With us today are Michael S. Weiss, Lindsay A. Rosenwald, Christian Béchon, Neil Herskowitz, Barry Salzman, and Scott Boilen. Also virtually present today is JT Scheriff of BDO USA, our independent auditors for the fiscal year ended December 31, 2021. Matthew Mamak of Alston & Bird, our legal counsel, and Peter Descovich of Broadridge Financial Solutions, who will serve as Secretary and Inspector of Elections of the meeting.
All stockholders of record as of April 18, 2022, are entitled to vote at this virtual meeting and have the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
